Lantheus Holdings (LNTH) Other Non Operating Income (2014 - 2026)
Lantheus Holdings' (LNTH) quarterly Other Non Operating Income came in at $5.7 million in Q1 2026, up 7420.51% year-on-year from $75925.7 in Q1 2025, and up 1901.26% on a QoQ basis from -$317000.0 in Q4 2025.
Lantheus Holdings (LNTH) Other Non Operating Income (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has 13 years of Other Non Operating Income data on file, last reported at $5.7 million in Q1 2026.
- On a quarterly basis, Other Non Operating Income rose 7420.51% year-over-year to $5.7 million in Q1 2026; TTM through Mar 2026 was $4.8 million, a 2188.21% increase from a year earlier, with the FY2025 full-year figure at -$1.0 million, down 1624.24% from the prior year.
- Other Non Operating Income for Q1 2026 stood at $5.7 million, up from -$317000.0 in the prior quarter.
- Over the last five years, Other Non Operating Income for LNTH reached as high as $52.6 million in Q3 2023 and fell as low as -$58.2 million in Q4 2023.
- Historically, Other Non Operating Income has averaged $856058.8 across 5 years, with a median of $46000.0 in 2024.
- Across the five-year window, Other Non Operating Income sank 9607.33% in 2023 and soared 7420.51% in 2026, its largest moves.
- Year by year, Other Non Operating Income stood at -$600000.0 in 2022, then sank by 9607.33% to -$58.2 million in 2023, then jumped by 100.44% to $258000.0 in 2024, then sank by 222.87% to -$317000.0 in 2025, then soared by 1901.26% to $5.7 million in 2026.
- Per Business Quant data, the three most recent Other Non Operating Income figures were $5.7 million in Q1 2026, -$317000.0 in Q4 2025, and -$269000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Lantheus Holdings | 6.72 Bn | 6.22 Bn | 230.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.71 Mn |
| Dec 31, 2025 | -317,000.00 |
| Sep 30, 2025 | -269,000.00 |
| Jun 30, 2025 | -342,000.00 |
| Mar 31, 2025 | -78,000.00 |
| Dec 31, 2024 | 258,000.00 |
| Sep 30, 2024 | 46,000.00 |
| Jun 30, 2024 | -455,000.00 |
| Mar 31, 2024 | 8.79 Mn |
| Dec 31, 2023 | -58.24 Mn |
| Sep 30, 2023 | 52.65 Mn |
| Jun 30, 2023 | 4.48 Mn |
| Mar 31, 2023 | 3.23 Mn |
| Dec 31, 2022 | -600,000.00 |
| Sep 30, 2022 | -1.10 Mn |
| Jun 30, 2022 | 310,000.00 |
| Mar 31, 2022 | 485,000.00 |
| Sep 30, 2021 | -3.94 Mn |
| Jun 30, 2021 | 182,000.00 |
| Mar 31, 2021 | 900,000.00 |